Assessing Performance of a Hepatitis C Emergency Department (HepC-EnD) Screening Tool: IT Integration Process for Electronic Health Record System
Part of paid clinical trials in Gainesville, Florida.
- Sponsor
- University of Florida
- Study ID
- NCT07406490
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- HIV (Human Immunodeficiency Virus)
- Hepatitis C Virus (HCV)
- Hepatitis C Virus (HCV) Infection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 79 Years
- Healthy Volunteers
- Accepted
Interventions
- Physician-Initiated Screening (Conventional Screening) — OTHERScreening for HCV and HIV in patients presenting to the ED occurs when an ED provider initiates screening based on symptoms or clinical judgement. Providers will manually order individual tests in the EHR.
- FOCUS (Universal Screening) — OTHERDuring nurse triage, a FOCUS screening question will appear in the EHR and the patient will be asked to opt-in to HCV and HIV testing. For those who consented, if an ED provider enters a phlebotomy order for any reason in the EHR, a BPA will alert the providers to suggest HCV and HIV testing. The provider can decide to "order" or "do not order" for each test individually. Ordered tests automatically trigger the following in the EHR: HCV antibody with reflex to RNA and HIV 1/2 antigen/antibody with reflex to confirmation. For all patients who received positive test result in the ED, standardized linkage-to-care processes will be performed. These procedures are currently implemented in clinical practice.
- HepC-EnD (Targeted Screening) — OTHERHepC-EnD will run in real time once integrated into the hospital's Epic EHR system. When the patient comes to the ED waiting room, a risk score generated from HepC-EnD will be available and determine if the patient is at high risk of HCV infection (\> cutoff risk score). If the patient is determined to be at high risk, a HepC-EnD screening question will appear in the EHR during nurse triage and the patient will be asked will be asked to opt-in to HCV and HIV testing. For those who consented, a BPA will alert the ED provider to suggest HCV and HIV testing. The provider can decide to "order" or "do not order" for each test individually. Ordered tests automatically trigger the following in the EHR: HCV antibody with reflex to RNA and HIV 1/2 antigen/antibody with reflex to confirmation. For all patients who received positive test result in the ED, standardized linkage-to-care processes will be performed.
Study Details
The goal of this observational study is to develop, implement, and evaluate a machine learning algorithm-based Hepatitis C Emergency Department (HepC-EnD) screening tool for use in emergency departments (EDs) to identify patients at high risk of hepatitis C virus (HCV) infection. HepC-EnD will be integrated into the University of Florida Health electronic health record (EHR) system as a best practice alert (BPA) pop-up for ED providers, notifying them of patients at high risk for HCV infection and recommending both HCV and human immunodeficiency virus (HIV) screening. Investigators aim to enhance the screening and diagnosis of individuals who may otherwise remain undiagnosed and untreated. The implementation outcomes (e.g., usability) and effectiveness outcomes (e.g., HCV screening and diagnosis rates) of HepC-EnD targeted screening will be compared with universal screening (FOCUS) and conventional physician-initiated screening programs in EDs.
Key Dates
- Start date
- Jul 1, 2026
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 6,466 participants (estimated)
Arms
- Arm: UF Jacksonville North EDPatients presenting to UF Jacksonville North ED who opt-in for HCV screening during nurse triage.
- Arm: UF Jacksonville Downtown EDPatients presenting to UF Jacksonville Downtown ED who opt-in for HCV screening during nurse triage (pre- and post-implementation).
- Arm: UF Gainesville EDPatients presenting to UF Gainesville ED (pre-implementation) and patents presenting to UF Gainesville ED who opt-in for HCV during nurse triage (post-implementation).
Primary Outcome Measure
Proportion of new HCV or HIV diagnoses [ Time Frame: Time Frame: 6 months pre- and post-implementation ]
Central Contacts
- Haesuk Park, PhD352-273-6261
- Khoa A Nguyen, PharmD352-273-9418
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UF Health Shands Emergency Room / Trauma Center | Gainesville | Florida | 32608 | - |
| UF Health Jacksonville Emergency Room | Jacksonville | Florida | 32209 | - |
| UF Health North Emergency Room | Jacksonville | Florida | 32218 | - |
Find similar trials in Gainesville, FL
Related Studies
- A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIVPHASE2 · Recruiting · Naga P. Chalasani · Birmingham, Alabama
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidEPHASE4 · Not Yet Recruiting · CAN Community Health · Clearwater, Florida
- Pre-exposure Prophylaxis (PrEP) for HealthRecruiting · Brown University · Cambridge, Massachusetts
- Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIVPHASE2 · Not Yet Recruiting · Weill Medical College of Cornell University · New York, New York